📉 Nikkei is down nearly 5% -> here are 43 recession-proof Japanese stocks from our screenerUnlock Now

Radiopharm Theranostics and Blackstone Minerals receive tax refunds to further their R&D

Published 28/03/2023, 11:13 am

Research and development (R&D) tax refunds have been granted to Radiopharm Theranostics Ltd (ASX:RAD) and Blackstone (NYSE:BX) Minerals Ltd (ASX:BSX, OTCQX:BLSTF) in recognition of the strong work they are doing in their very different fields.

Tax refunds serve two purposes: to highlight advancements and to fill up the coffers so the forward momentum can continue.

RAD received a $1.56 million refund for its research and development activities throughout the 2022 financial year.

The clinical-stage radiotherapeutics company will use the money to continue the development of its portfolio of radiopharmaceutical products for diagnostic and therapeutic applications.

RAD has a pipeline of six distinct and highly differentiated platform technologies spanning peptides, small molecules and monoclonal antibodies for use in cancer, in pre-clinical and clinical stages of development from some of the world’s leading universities and institutes.

The clinical program includes one Phase II and three Phase I trials in a variety of solid tumour cancers including breast, kidney and brain.

Just this week, RAD inked a multi-year strategic research partnership with GenesisCare, a leading global provider of integrated cancer care and theranostic research, to conduct Phase 1 clinical trials in Australia to study the safety and tolerability of novel radiopharmaceuticals.

Read: Radiopharm Theranostics forms multi-year strategic research partnership with GenesisCare to develop radiopharmaceuticals

Blackstone developing refinery process

Blackstone received A$3.8 million from the Australian Tax Office (ATO), in recognition of technical advancements it made during the last financial year.

The company has made significant investment to develop the Ta Khoa Refinery process with ATO recognising the company’s unique strategy to convert nickel concentrate blends into battery products in the form of precursor cathode active material (pCAM).

Blackstone invested heavily in process development and piloting programs and expects to have approximately $16 million cash and cash equivalents at the end of the March quarter including the refund.

Recently, the company completed its second assessment with Digbee ESG, an industry-standard ESG disclosure framework, to support the development of the Ta Khoa Project in northern Vietnam.

Read: Blackstone Minerals' ESG assessment of Ta Khoa Project in Vietnam shows clear improvements

Read more on Proactive Investors AU

Disclaimer

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.